Home  >  TopNews
you can get e-magazine links on WhatsApp.Click here
Pioma_Lactic
Corporate + Font Resize -

Gujarat FDCA commissioner inaugurates Ortiv-Q3, pharma research & analytical lab in Ahmedabad

Yash Ved, Mumbai
Thursday, October 14, 2021, 08:00 Hrs  [IST]

The Gujarat Food and Drug Control Administration (FDCA) commissioner HG Koshia has inaugurated the state-of-the-art pharmaceutical research and analytical laboratory in Ahmedabad which is a collaborative effort between the SOTAX Group and Ortiv-Q3.

Recently, SOTAX Group and Ortiv-Q3 had announced their collaboration, further strengthening their capabilities in the field of pharma services.

The inauguration took place in presence of rolf benz, ceo and president of the board of SOTAX Group.

The laboratory facility is spread over of 10,000 sq.ft. and is a new, state-of-the-art infrastructure including modern workspace and set of latest instruments to perform current good manufacturing practices (cGMP) analytical services with a clear focus on complex dosage forms characterization.

The new infrastructure will facilitate accelerating complex formulation development programme of global clients and shall work with a high throughput to perform excellent services to the customers. Soon, the lab will be accredited by various regulatory agencies.

“It will be one of the finest labs in the country specifically in Gujarat,” Koshia said.

The new lab will offer various routine analytical services and stability studies, clinical and commercial batch release, analytical method validation, method transfer and R&D services like in vitro release testing (IVRT, USP type 1-7), IVPT, reverse engineering, Q3 characterization (physico-chemical), API screening & impurities characterization and it would also support services like troubleshooting & investigations, training, consulting, audits, support for Q1/ Q2 regulatory clearance.

The SOTAX Group, headquartered in Switzerland, is the leading global provider of complete testing solutions for R&D, quality control (QC), and in-process control (IPC) departments of the pharmaceutical industry.

The Ortiv-Q3 company, founded by enthusiastic and experienced pharma professionals (Mukesh Kumar, Pawan Gupta and Ashish Gupta), provides a complete suite of drug release testing for a variety of dosage forms ranging from simple tablets to complex formulations like microspheres, suspensions, emulsions, nano-dispersions, liposomal and topical formulations.

 

*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |